Abbott's St. Jude Deal Aligns With Shift To Value-Based Care

The Federal Trade Commission’s approval of Abbott Laboratories’ $25 billion purchase of St. Jude Medical helps the larger company cope with value-based care and bundled payments to doctors and hospitals.